C., Krishnappa, D., Adkisson, W
This month's Broker Brief breaks down: - Why up to 65% of GLP-1 users discontinue within a year, and why that turns coverage into a sunk cost for employers - What oral GLP-1s like Lilly's Foundayo mean for demand, when most plans still have eligibility rules written for injectables only - How fast a PBM formulary decision can move, using this year's Zepbound to Wegovy switch and back as the case in point - Why 38% of employers already tie GLP-1 coverage to participation in a lifestyle or behavioral program If you're advising employers on GLP-1 coverage, this is where the conversation is heading
Mediation analyses demonstrated that the robust decrease in urinary albumin-to-creatinine ratio occurred largely independently of systemic BP lowering, suggesting complementary tissue-protective, anti-inflammatory, antifibrotic, and renal-hemodynamic mechanisms beyond simple antihypertensive effects
So lets jump in
Las grasas juegan diferentes papeles en nuestro organismo, entre los que destacan su funcin estructural, de reserva y aporte energtico, protectora y de aislante trmico, as como su funcin reguladora al actuar algunos lpidos como hormonas y vitaminas